FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome: Moreover, this work formally proves the need of maintaining endogenous FOXP3 gene regulation, such as by gene editing approaches or the use of lentiviral vectors containing endogenous FOXP3 regulatory regions, in HSC-based gene therapy for IPEX disease.